P-279 Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia

Rezultati

Naziv:	P-279 Cetuximab as third line treatment of metastatic colorectal carcinoma (mCRC) – 5-year experience from the Institute of Oncology and Radiology of Serbia
Autori:	Spasic, Jelena ; Stanic, Nemanja; Ristic, Marija; Djordjevic, Feđa; Nikolic, Neda ; Nikolić, Vladimir ; Pupovac, S.; Radosavljević, Davorin
Godina:	2015
Publikacija:	ANNALS OF ONCOLOGY. ESMO- 2015 European Society for Medical Oncology. Abstracts/ Posters.
ISSN:	0923-7534 Annals of Oncology Pretraži identifikator
Izdavač:	ESMO. European Society Medical Oncologists, Elsevier.
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 26 str. iv82-iv82
DOI:	10.1093/annonc/mdv233.276
URI:	https://enauka.gov.rs/handle/123456789/483830
URL:	https://www.annalsofoncology.org/article/S0923-7534(19)50809-2/fulltext https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2819%2950809-2
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Alt metrika

Dimensions

Unpaywall

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.